A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy of ABT-751 when administered in combination with standard
pemetrexed in subjects with advanced or metastatic NSCLC. The Phase 1 portion of the study is
complete and the study is currently enrolling subjects in Phase 2.